Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotechnology symbols : LLY save search
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
Published: 2024-03-26 (Crawled : 11:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.14%
H: 0.53%
C: 0.09%
expansion therapeutics
Sermonix Pharmaceuticals Announces MBC Alliance Membership, New ‘Discover ELAINE’ Website
Published: 2024-02-12 (Crawled : 15:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: -0.48%
pharmaceuticals
The Top 11 Biopharma Companies Hiring Now
Published: 2024-02-08 (Crawled : 15:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.41%
H: 1.74%
C: 1.01%
companies biopharma
Jaguar Gene Therapy Announces FDA Clearance of IND to Study JAG201 in a Genetic Form of Autism Spectrum Disorder and Phelan-McDermid Syndrome
Published: 2024-01-31 (Crawled : 15:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.84%
H: 2.02%
C: -0.73%
jag201 fda genetic clearance therapy study
Top 5 Biopharma Companies Hiring Engineers
Published: 2024-01-25 (Crawled : 07:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -1.0%
H: 0.84%
C: 0.04%
companies biopharma
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
Published: 2023-11-30 (Crawled : 08:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.01%
H: 0.81%
C: -0.07%
FGEN | $1.29 -1.53% -1.55% 860K
|
Health Technology
|
| O: 6.3%
H: 11.13%
C: 4.23%
pharma
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
Published: 2023-11-01 (Crawled : 11:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -2.76%
H: 0.0%
C: 0.0%
UTHR | $231.715 -1.43% -1.45% 500K
|
Health Technology
|
| O: -5.01%
H: 7.34%
C: 5.85%
corporation therapeutics financial results
Mablink Bioscience Enters an Agreement to be Acquired by Lilly
Published: 2023-10-18 (Crawled : 22:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.18%
H: 1.42%
C: 0.0%
bioscience acquired agreement
Mariana Oncology Announces $175 Million Series B Financing
Published: 2023-09-07 (Crawled : 12:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.76%
H: 2.15%
C: 1.6%
series
AltPep Corporation Announces Close of $53 Million Series B Financing to Advance Its Novel Therapeutics for both Alzheimer’s and Parkinson’s Diseases into the Clinic
Published: 2023-06-22 (Crawled : 13:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.44%
H: 1.6%
C: 0.59%
alzheimer’s corporation parkinson’s therapeutics
Switch Therapeutics Launches with $52 Million to Advance First-of-its-Kind RNAi Technology
Published: 2023-03-14 (Crawled : 12:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.14%
H: 1.0%
C: 0.93%
technology therapeutics
TRexBio Announces Collaboration and License Agreement with Lilly to Develop and Commercialize Novel Therapies for Immune-Mediated Diseases
Published: 2023-01-09 (Crawled : 13:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
collaboration license agreement
Reports: Neuro-Focused Faze Medicines to Shutter Operations
Published: 2022-11-10 (Crawled : 14:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 1.09%
H: 0.48%
C: 0.4%
Lacerta and Prevail, A Wholly Owned Subsidiary of Lilly, Sign Agreement to Develop Novel AAV Capsids for CNS Disorders
Published: 2022-08-23 (Crawled : 10:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.58%
H: 0.19%
C: -1.91%
wholly agreement
Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using the Genesis Molecular AI Platform
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -1.31%
H: 0.0%
C: 0.0%
collaboration therapeutics molecular platform therapy
AIVITA Biomedical Appoints Dr. H. Christian Fibiger to its Board of Directors
Published: 2022-04-05 (Crawled : 12:20) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.1%
H: 1.41%
C: 0.26%
Entos Pharmaceuticals Announces Senior Leadership Appointments to Expand Executive Team and Accelerate Growth
Published: 2022-03-03 (Crawled : 14:30) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 2.08%
H: 1.86%
C: 1.5%
LJPC | $6.22 0.0%
|
Health Technology
|
| O: 1.9%
H: 1.63%
C: -2.33%
als ces cel growth
Aktis Oncology Expands Leadership Team with Two Strategic Hires
Published: 2022-01-18 (Crawled : 16:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -3.01%
H: 2.38%
C: 1.78%
The BioMidwest Region Features Lifestyle Bonuses and Cutting-Edge Science
Published: 2021-07-26 (Crawled : 13:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 1.53%
H: 1.12%
C: 0.26%
Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
Published: 2021-07-08 (Crawled : 12:00) - biospace.com/
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: -0.84%
H: 1.47%
C: 1.41%
treatment collaboration genomic
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.